Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Jun 08, 2022 3:57pm
145 Views
Post# 34741500

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Big Pharma is facing a looming $236 Billion patent cliff

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Big Pharma is facing a looming $236 Billion patent cliffI agree, no correlation yet for future success. My information is taken directly from the onc website and their investor presentation. Simple as that, so you have to decide if you believe wikepedia or the onc website but would make more sense to quote relevant information directly from the source unless you do not believe them. I honestly think that people here would like to hear the truth so was only trying to clarify what you were saying and do not really think that you should have a problem with that, My problem was not with you, only the information that you were relaying was not correct and that's all there is to it. So here's hoping that we all move forward and that onc does the same with some hopeful relevant updates for all of the shareholders and with that maybe some institutional investors helping the cause and sp at the same time. We shall all know soon enough would be my guess.
<< Previous
Bullboard Posts
Next >>